Market Access focus: The changing landscape of patient access to new medicines

Read this article in our Pf Magazine Market Access Special Edition here.  In a constantly changing market access landscape, industry has a greater range of...

Market Access focus: What does modern market access really mean?

Read this article in our Pf Magazine Market Access Special Edition here.  There is no one definition for modern market access – what does it...

Market Access focus: Where are we now?

Read this article in our Pf Magazine Market Access Special Edition here.  The PM Society Market Access interest group (MAIG) recently conducted a needs analysis...

“Life-changing” developments in the treatment of severe asthma

Asthma is one of the most prevalent long term conditions in the UK, affecting 5.4 million people, of whom nearly three million take treatment....

Duchenne UK works hard to find a cure for DMD

Duchenne UK’s co-founder and joint CEO Emily Crossley shares her vision for finding a cure for Duchenne Muscular Dystrophy (DMD) patients. DMD is a devastating...

What is being done in the fight against ovarian cancer?

  March is Ovarian Cancer Awareness Month. Early detection of this devastating disease is essential. What’s being done? Ovarian cancer kills 11 women every day in...

Hunt hangs on for health and social care future

  Accountability in Health and Social Care, and the incredible unsinkable Health Secretary Earlier this year, Jeremy Hunt somehow survived another Cabinet reshuffle. His ability to...

Tackling antimicrobial resistance: What’s new?

  1. Supercharge me Researchers at the University of Queensland (UQ) in Australia have ‘supercharged’ an old antibiotic using a technique that could potentially lead to the...

Heart-stopping poison – key to a male contraceptive?

  Could a heart-stopping poison hold the key to a male contraceptive pill?   Don’t believe the hype: health headlines dissected     THE...

Are young people excited by a career in industry?

  Breakthroughs, tech and innovation are abundant, but are young people excited by a career in industry? Ask children what they want to do with the...

Latest articles

NHS trusts face worryingly high levels of senior vacancies

Why is high turnover among board-level roles make a negative impact on the performance of NHS trusts?

Triumph for Roche’s flu drug in phase III study

Roche has announced that the phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications...

Leading Alzheimer’s Disease scientist joins NeuroCog Trials

Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimer’s Disease research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice President...